Gancitano G, Ravasio R, Dionisi M, et al. Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer. Farmeconomia. Health Economics and Therapeutic Pathways. 2018;19(1). https://doi.org/10.7175/fe.v19i1.1354